A New York City TIMES BESTSELLER New York Times 100 Noteworthy Books of 2019 New York Public Library Best Books of 2019 Kirkus Reviews Best Health and Science Books of 2019 Science Friday Finest Books of 2019 Brand-new postscript by the author From an acclaimed reporter, an explosive narrative investigation of the generic drug boom that reveals scams and deadly dangers on an international scale– The Jungle for pharmaceuticals Numerous have hailed the widespread usage of generic drugs as one of the most crucial public-health developments of the twenty-first century. Today, practically 90 percent of our pharmaceutical market is comprised of generics, the majority of which are produced overseas. We have been reassured by our physicians, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just more economical. Is this truly real? Katherine Eban’s Bottle of Lies exposes the deceit behind generic-drug manufacturing– and the attendant threats for worldwide health. Making use of unique accounts from whistleblowers and regulators, along with countless pages of private FDA files, Eban exposes an industry where fraud is rampant, companies consistently falsify information, and executives prevent almost every principle of safe production to lessen expense and optimize revenue, confident in their capability to deceive inspectors. On the other hand, patients unwittingly consume medication with unpredictable and harmful effects. The story of generic drugs is truly international. It connects middle America to China, India, sub-Saharan Africa and Brazil, and represents the ultimate litmus test of globalization: what are the dangers of moving drug production offshore, and are they worth the savings? A decade-long examination with global sweep, high-stakes brinkmanship and huge money at its core, Bottle of Lies reveals how the world’s greatest public-health development has become one of its most impressive swindles.
No comments:
Post a Comment